The incidence of trisomy 3 in splenic lymphoma with villous lymphocytes: a study by FISH

被引:26
作者
Gruszka-Westwood, AM
Matutes, E
Coignet, LJA
Wotherspoon, A
Catovsky, D
机构
[1] Royal Marsden NHS Trust, Acad Dept Haematol & Cytogenet, London SW3 6JJ, England
[2] Royal Marsden NHS Trust, Canc Res Inst, Dept Histopathol, London SW3 6JJ, England
关键词
SLVL; SMZL; trisomy; 3; interphase FISH;
D O I
10.1046/j.1365-2141.1999.01209.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Splenic lymphoma with villous lymphocytes (SLVL) is a low-grade B-cell lymphoproliferative disorder characterized by splenomegaly and circulating villous lymphocytes. The relationship between SLVL and splenic marginal zone lymphoma (SMZL), a disorder with identical splenic histology to SLVL, is not clear. Previous studies have failed to show a consistent karyotypic abnormality in SLVL whereas trisomy 3 has been reported in patients with SMZL. The presence of trisomy 3 in SMZL and its absence in SLVL has been viewed as evidence that these are different diseases. However, it is possible that the frequency of trisomy 3 in SLVL has been underestimated because previous studies hare relied on conventional cytogenetics. We have therefore used interphase fluorescence in situ hybridization (FISH) to re-assess the frequency of trisomy 3 in SLVL, We studied 70 patients, who were stratified into four groups according to the percentage of circulating villous lymphocytes. Trisomy 3 was found overall in 17% of patients, Tn particular, trisomy 3 was detected in 13% of cases with >50% of villous lymphocytes and which were considered typical of SLVL. In conclusion, we have demonstrated that some patients with SLVL have circulating cells with trisomy 3, which does not support the view that SLVL and SMZL are different diseases on the basis of the incidence of trisomy 3.
引用
收藏
页码:600 / 604
页数:5
相关论文
共 26 条
[1]  
APLAN PD, 1995, CANCER RES, V55, P1917
[2]  
Brynes RK, 1996, MODERN PATHOL, V9, P995
[3]   Detection of 11q13 rearrangements in hematologic neoplasias by double-color fluorescence in situ hybridization [J].
Coignet, LJA ;
Schuuring, E ;
Kibbelaar, RE ;
Raap, TK ;
Kleiverda, KK ;
Bertheas, MF ;
Wiegant, J ;
Beverstock, G ;
Kluin, PM .
BLOOD, 1996, 87 (04) :1512-1519
[4]   Marginal zone B-cell lymphomas including mucosa-associated lymphoid tissue type lymphoma (MALT), monocytoid B-cell lymphoma and splenic marginal zone cell lymphoma and their relation to the reactive marginal zone [J].
DeWolfPeeters, C ;
Pittaluga, S ;
Dierlamm, J ;
Wlodarska, I ;
VandenBerghe, H .
LEUKEMIA & LYMPHOMA, 1997, 26 (5-6) :467-478
[5]   BCL6 gene rearrangements also occur in marginal zone B-cell lymphoma [J].
Dierlamm, J ;
Pittaluga, S ;
Stul, M ;
Wlodarska, I ;
Michaux, L ;
Thomas, J ;
Verhoef, G ;
Verhest, A ;
Depardieu, C ;
Cassiman, JJ ;
Hagemeijer, A ;
DeWolfPeeters, C ;
VandenBerghe, H .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (03) :719-725
[6]   Trisomy 3 in marginal zone B-cell lymphoma: A study based on cytogenetic analysis and fluorescence in situ hybridization [J].
Dierlamm, J ;
Michaux, L ;
Wlodarska, I ;
Pittaluga, S ;
Zeller, W ;
Stul, M ;
Criel, A ;
Thomas, J ;
Boogaerts, M ;
Delaere, P ;
Cassiman, JJ ;
DeWolfPeeters, C ;
Mecucci, C ;
VandenBerghe, H .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (01) :242-249
[7]  
Dierlamm J, 1996, BLOOD, V87, P299
[8]   Interphase cytogenetics in chronic lymphocytic leukemia [J].
GarciaMarco, JA ;
Price, CM ;
Catovsky, D .
CANCER GENETICS AND CYTOGENETICS, 1997, 94 (01) :52-58
[9]  
GILLINGHAM R, 1998, BRIT J HAEMATOLOG S1, V101
[10]  
HARRIS NL, 1994, BLOOD, V84, P1361